๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This study is designed to assess the safety and ability of BioThrax and AV7...
Status
Completed
Location
Johnson County Clin-Trials
Start Date
2018-05-09
Trial ID
NCT03518125
Treatments Being Tested
This is a dose ranging study comparing different vaccine schedules of rPA v...
Status
Completed
Location
Greater Huntsville Family Practice, PC
Start Date
2005-03
Trial ID
NCT00170469
Treatments Being Tested
Anthrax Clinical Trial Objectives: To assess whether: * Anthrax vaccine (...
Status
Completed
Location
University of Alabama, Birmingham (UAB)
Start Date
2002-05
Trial ID
NCT00119067
Treatments Being Tested
This study will provide preliminary safety and comparative immunogenicity d...
Status
Completed
Location
Walter Reed Army Institute of Research / Henry M. Jackson Foundation Vaccine Clinical Research Center, 1600 East Gude Dr
Start Date
2003-04
Trial ID
NCT00057525
Treatments Being Tested
The purpose of this phase 1 study is to evaluate the safety and immunogenic...
Status
Completed
Location
Emory University School of Medicine
Start Date
2003-06
Trial ID
NCT00103467
Treatments Being Tested
1. BACKGROUND The newly developed anthrax vaccine GC1109 has been proven sa...
Status
Completed
Location
Seoul National University Hospital
Start Date
2009-02
Trial ID
NCT01867957
Treatments Being Tested
The purpose of this study is to evaluate 2 vaccine candidates against anthr...
Status
Completed
Location
The Center for Pharmaceutical Research
Start Date
2013-11
Trial ID
NCT01979406
Treatments Being Tested
The purpose of this study is to assess the safety and immunogenicity of rPA...
Status
Completed
Location
UCLA Ctr for Vaccine Research, LA Biomedical Research Institute
Start Date
2004-04
Trial ID
NCT00100724
Treatments Being Tested
The purpose of this study is to evaluate the safety for up to two doses of ...
Status
Completed
Location
JBR Clinical Research
Start Date
2020-06-15
Trial ID
NCT04415749
Treatments Being Tested
This study will examine pathophysiology and immune response of anthrax in i...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2002-10-31
Trial ID
NCT00050310